drugset / Trial / NCT00199095

Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

NCT00199095

Phase 4 Completed 40 enrolled Goethe University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of this study is to test feasibility and efficacy of a dose reduced chemotherapy in elderly patients with newly diagnosed acute lymphoblastic leukemia. The regimen consists of induction phase I and II followed by cyclic consolidation cycles, reinduction and maintenance therapy

Timeline

Start
1997-02
Primary completion
2003-06
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified
Subject Cytarabine Small molecule
Subject Dexamethasone Small molecule
Subject Doxorubicin Other / unclassified
Subject Idarubicin Small molecule
Subject Ifosfamide Small molecule
Subject MERCAPTOPURINE ANHYDROUS Small molecule
Subject Methotrexate Small molecule
Subject Teniposide Small molecule
Subject Vincristine Small molecule